Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    DICE Therapeutics Inc.

    NASDAQ: DICE · Real-Time Price · USD
    47.55
    0.03 (0.06%)
    At close: Aug 08, 2023, 10:00 PM

    DICE Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 1.13M
    Cost of Revenue
    		 n/a n/a
    Gross Profit
    		 n/a 1.13M
    Operating Income
    		 -88.22M -47.6M
    Interest Income
    		 5.21M 136K
    Pretax Income
    		 -83.89M -48.96M
    Net Income
    		 -81.66M -48.47M
    Selling & General & Admin
    		 25.66M 12.22M
    Research & Development
    		 62.56M 36.51M
    Other Expenses
    		 n/a n/a
    Operating Expenses
    		 88.22M 48.73M
    Interest Expense
    		 679K 174K
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 88.22M 48.73M
    Income Tax Expense
    		 -2.22M -487K
    Shares Outstanding (Basic)
    		 39.4M 12.38M
    Shares Outstanding (Diluted)
    		 39.4M 12.38M
    EPS (Basic)
    		 -2.07 -3.91
    EPS (Diluted)
    		 -2.07 -3.91
    EBITDA
    		 -83.01M -47.47M
    EBIT
    		 -83.21M -48.78M
    Depreciation & Amortization
    		 5.21M 136K

    Add to Watchlist